Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 01, 2023 08:30 ET | Source: RespireRX Pharmaceuticals Inc.

ResolutionRx Ltd, a wholly owned subsidiary of RespireRx Pharmaceuticals Inc. Enters into LOI and Term Sheet with Radium Capital for the financing of anticipated Research and Development Credits

Glen Rock, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
December 05, 2022 08:30 ET | Source: RespireRX Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc. Enters a Collaboration With National Institute for Neurological Disorders and Stroke to Advance its Lead GABAkine Toward Clinical Development

Glen Rock, N.J., Dec. 05, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
July 28, 2022 09:15 ET | Source: Innospec Inc.

Innospec Secures Land for Future Expansion at its Primary Personal Care Manufacturing Facility

ENGLEWOOD, Colo., July 28, 2022 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announces the purchase of land which significantly increases the acreage available for future expansion at its...
June 14, 2022 10:00 ET | Source: GRAID Technology

Exxact Corporation Releases New GRAID SupremeRAID™ Powered NVMeoF Storage Solution for AI and HPC Workloads

SANTA CLARA, Calif., June 14, 2022 (GLOBE NEWSWIRE) -- Exxact Corporation, a North America-based leading provider of high-performance computing (HPC), artificial intelligence (AI), and data center...
March 07, 2022 08:00 ET | Source: RespireRX Pharmaceuticals Inc.

Letter to Stockholders and Other Stakeholders: A Brief Summary of Our Progress During Past Twelve Months and a Peek Looking Forward

Glen Rock, N.J., March 07, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
January 12, 2022 08:00 ET | Source: Shaw Communications Inc.

Shaw Announces First Quarter Fiscal 2022 Results

First quarter consolidated financial results include adjusted EBITDA1 growth of 4.3% and free cash flow1 of $236 million The Company continues to focus on balancing growth and profitability and...
November 29, 2021 08:45 ET | Source: RespireRX Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc. Announces Publication of Preclinical Results Supporting the Use of AMPAkines in the Treatment of Human Spinal Cord Injury

Glen Rock, N.J.,, Nov. 29, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...
November 04, 2021 08:45 ET | Source: RespireRX Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO

Glen Rock, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), (“RespireRx” or the “Company”) a leader in the discovery and development of innovative and...
July 06, 2021 09:15 ET | Source: Innospec Inc.

Innospec Expands Mild, Natural, Sulfate-Free Performance Chemicals Manufacturing Capacity

ENGLEWOOD, Colo., July 06, 2021 (GLOBE NEWSWIRE) -- To meet accelerating demand for its innovative, industry-leading, mild and sustainability-focused surfactants, Innospec has announced further...
January 05, 2021 16:05 ET | Source: RespireRX Pharmaceuticals Inc.

RespireRx Pharmaceuticals Inc. Announces 10 to 1 Reverse Stock Split

Glen Rock, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company” or “we”), has, on January 4, 2021, filed with the Secretary of State of...